Suzanne Baron, MD
Interventional Cardiology · Boston, MANPI 1619003324
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.7%. 2025 is the largest year on record at $66,287, 5.8 times the $11,439 reported in 2019. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 471 payments — averaging $581.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$65K
- Abbott$53K
- Medtronic$36K
- Edwards Lifesciences$35K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$26K
- Abiomed$24K
- plus $35K from 14 others
Across 40 payments — averaging $89,513 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$3.4M
- Edwards Lifesciences$89K
- Shockwave Medical, Inc$84K
- Magenta Medical Inc$24K
- Medtronic$350
What the payments were for
- Consulting fees$140,51751%
- Speaking & faculty fees$102,03537%
- Grants$1350%
- Travel & lodging$15,1696%
- Food & beverage$14,6545%
- Education$1,3851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 88 | $64,917 |
| Abbott | 126 | $52,850 |
| Medtronic(2 entities) | 105 | $36,060 |
| Edwards Lifesciences | 69 | $34,564 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $26,427 |
| Abiomed | 26 | $24,335 |
| Heartflow, Inc. | 9 | $12,588 |
| Shockwave Medical, Inc | 7 | $9,725 |
| Biotronik Inc. | 10 | $4,101 |
| CSL Behring | 1 | $2,535 |
| Janssen Research & Development, LLC | 2 | $1,620 |
| Croivalve Inc | 1 | $1,500 |
| Recor Medical Inc | 1 | $900 |
| ZOLL Circulation Inc | 2 | $744 |
| Terumo Medical Corporation | 1 | $350 |
| Chiesi USA, Inc. | 3 | $327 |
| Philips North America LLC | 2 | $191 |
| Inari Medical, Inc. | 1 | $117 |
| Corindus Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$26,139
- Impella$23,840
- GENERAL - THERAPIES$22,154
- COREVALVE EVOLUT R$20,503
- GENERAL VASCULAR ACCESS$12,671
- FFRct$12,525
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$9,350
- GENERAL - STRUCTURAL HEART$8,750
- Tendyne Mitral Valve System$8,082
- Sentinel$7,375
- General - CT_IC$7,172
- TENDYNE$4,550
- Pulsar$3,224
- Orsiro$3,224
- PK Papyrus$3,224
- Astron; Pulsar; AstronPulsar$3,224
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,383
- Passeo$2,000
- PRO-Kinetic Energy$1,224
- Paradise Ultrasound Renal Denervation System$900
How this compares
$273,894 in reported general payments places this provider in the 95th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 17 | $404 |
| Rosuvastatin Calcium | 19 | $312 |
| Atorvastatin Calcium | 31 | $298 |
| Lisinopril | 13 | $107 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boston
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Farouc JafferBoston$213K
- Joseph GarasicBoston$152K
- Pinak ShahBoston$147K
- Douglas DrachmanBoston$132K
- Hector Tamez AguilarBoston$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.